NASDAQ · GDNR
Gardiner Healthcare Acquisitions Corp.
$10.90+$0.07 (+0.65%)
Gardiner Healthcare Acquisitions Corp.’s quoted price sits in the lower half of its reported 52-week range, 9.32% below the high.
Loading market information…
NASDAQ · PBAX · USD
Stock price, earnings
Quote as of Feb 14, 2024, 08:56 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Phoenix Biotech Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 54.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Phoenix Biotech Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.90+$0.07 (+0.65%)
Gardiner Healthcare Acquisitions Corp.’s quoted price sits in the lower half of its reported 52-week range, 9.32% below the high.
$10.81-$0.30 (-2.7%)
TG Venture Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 7.13% below the high.
$9.46-$1.50 (-13.69%)
Moringa Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
$4.09$0.00 (0.0%)
Iron Horse Acquisitions Corp. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 72.2% below the high.
$10.00+$1.58 (+18.76%)
Blue Safari Group Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 32.2% below the high.
$3.01-$6.15 (-67.14%)
A SPAC I Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 82.54% below the high.
$11.20+$0.09 (+0.81%)
Achari Ventures Holdings Corp. I’s quoted price sits in the upper half of its reported 52-week range, 10.04% below the high.
$4.40-$0.08 (-1.77%)
ConnectM Technology Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.3% below the high.
